Grant-Huerta Yanina — SEC Form 4 filings
SEC reporting owner CIK 2064348. 7 Form 4 filings on record with FilingPulse; latest filed 2026-08-17.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2025-05-20 to 2026-08-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 12 legs across 5 filings — 10,349 shares, $92,525 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 4.
- Largest priced transaction: sale of 2,414 shares @ $9.13 ($22,036) in Atara Biotherapeutics, Inc., filed 2026-05-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Atara Biotherapeutics, Inc. (ATRA) | Chief Accounting Officer | 6 | — | 12 legs · 10,349 sh · $92,525 | 1 |
| ImageneBio, Inc. (IMA) | Chief Financial Officer | 1 | — | — | 3 |
Form 4 filings — Grant-Huerta Yanina
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-17 | 4 | ImageneBio, Inc. (IMA) | Grant/award (A): 65,000 @ $0 · Grant/award (A): 39,000 @ $0 · Grant/award (A): 56,000 (derivative) @ $0 | EDGAR |
| 2026-05-20 | 4 | Atara Biotherapeutics, Inc. (ATRA) | Sale (S): 2,414 @ $9.13 | EDGAR |
| 2026-03-11 | 4 | Atara Biotherapeutics, Inc. (ATRA) | Grant/award (A): 20,300 @ $0 | EDGAR |
| 2026-03-04 | 4 | Atara Biotherapeutics, Inc. (ATRA) | Sale (S): 24 @ $5.08 · Sale (S): 1,603 @ $5.08 · Sale (S): 377 @ $5.08 · Sale (S): 100 @ $5.08 | EDGAR |
| 2025-11-19 | 4 | Atara Biotherapeutics, Inc. (ATRA) | Sale (S): 1,645 @ $13.19 · Sale (S): 85 @ $13.19 · Sale (S): 74 @ $13.19 | EDGAR |
| 2025-08-20 | 4 | Atara Biotherapeutics, Inc. (ATRA) | Sale (S): 55 @ $11.61 · Sale (S): 86 @ $11.61 · Sale (S): 1,668 @ $11.61 | EDGAR |
| 2025-05-20 | 4 | Atara Biotherapeutics, Inc. (ATRA) | Sale (S): 2,218 @ $6.76 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2064348 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →